Cargando…
Fluconazole-Resistant Candida glabrata Bloodstream Isolates, South Korea, 2008–2018
We investigated the clinical outcomes and molecular mechanisms of fluconazole-resistant (FR) Candida glabrata bloodstream infections. Among 1,158 isolates collected during multicenter studies in South Korea during 2008–2018, 5.7% were FR. For 64 patients with FR bloodstream infection isolates, the 3...
Autores principales: | Won, Eun Jeong, Choi, Min Ji, Kim, Mi-Na, Yong, Dongeun, Lee, Wee Gyo, Uh, Young, Kim, Taek Soo, Byeon, Seung Ah, Lee, Seung Yeob, Kim, Soo Hyun, Shin, Jong Hee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7920659/ https://www.ncbi.nlm.nih.gov/pubmed/33624581 http://dx.doi.org/10.3201/eid2703.203482 |
Ejemplares similares
-
Molecular and Clinical Features of Fluconazole Non-susceptible Candida albicans Bloodstream Isolates Recovered in Korean Multicenter Surveillance Studies
por: Choi, Min Ji, et al.
Publicado: (2023) -
Fluconazole-Resistant Candida parapsilosis Bloodstream Isolates with Y132F Mutation in ERG11 Gene, South Korea
por: Choi, Yong Jun, et al.
Publicado: (2018) -
Multilocus Sequence Typing (MLST) Genotypes of Candida glabrata Bloodstream Isolates in Korea: Association With Antifungal Resistance, Mutations in Mismatch Repair Gene (Msh2), and Clinical Outcomes
por: Byun, Seung A., et al.
Publicado: (2018) -
Antifungal Susceptibility to Amphotericin B, Fluconazole, Voriconazole, and Flucytosine in Candida Bloodstream Isolates from 15 Tertiary Hospitals in Korea
por: Jung, Sook-In, et al.
Publicado: (2012) -
In Vitro Fluconazole and Voriconazole Susceptibilities of Candida Bloodstream Isolates in Korea: Use of the CLSI and EUCAST Epidemiological Cutoff Values
por: Jang, Min Joong, et al.
Publicado: (2013)